The Library
Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study
Tools
Tools
Tools
McAloon, Christopher, Barwari, Temo, Hu, Jimiao, Hamborg, Thomas, Nevill, Alan, Hyndman, Samantha, Ansell, Valerie, Musa, Anntoniette, Jones, Julie, Goodby, Julie, Banerjee, Prithwish, O’Hare, Paul, Mayr, Manuel, Randeva, Harpal S. and Osman, Faizel (2018) Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study. Open Heart, 5 (2). e000899. doi:10.1136/openhrt-2018-000899
|
PDF
WRAP-biomarkers-cardiac-resynchronisation-CRT- COVERT-HF-Osman-2018.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons: Attribution-Noncommercial 4.0. Download (1411Kb) | Preview |
Official URL: http://dx.doi.org/10.1136/openhrt-2018-000899
Abstract
Aims Cardiac resynchronisation therapy (CRT) is effective treatment for selected patients with heart failure (HF) but has ~30% non-response rate. We evaluated whether specific biomarkers can predict outcome.
Methods A prospective single-centre pilot study of consecutive unselected patients undergoing CRT for HF between November 2013 and December 2015 evaluating cardiac extracellular matrix biomarkers and micro-ribonucleic acid (miRNA) expression before and after CRT assessing ability to predict functional response and survival. Each underwent three assessments (pre-implant, 6 weeks and 6 months postimplant) including: New York Heart Association (NYHA) class, echocardiography, electrocardiography, 6 min walk test (6MWT), Minnesota Living with Heart Failure Questionnaire (MLHFQ) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP). Plasma markers of cardiac fibrosis assessed were: N-terminal pro-peptides of collagen I and III, collagen I C-terminal telopeptides (CTx) and matrix metalloproteinases (MMP-2 and MMP-9) as well as a panel of miRNAs (miRNA-21, miRNA-30d, miRNA-122, miRNA-133a, miRNA-210 and miRNA-486).
Results A total of 52 patients were recruited; mean age (±SD) was 72.4±9.4 years; male=43 (82.7%), ischaemic aetiology=30 (57.7%), mean QRS duration=166.4±23.5 ms, left bundle branch block (LBBB) morphology = 39 (75.0%), mean NYHA=2.7±0.6, 6MWT=238.8±130.6 m, MLHFQ=46.4±21.3 and left ventricular ejection fraction (LVEF)=24.3%±8.0%. Mean follow-up=1.7±0.3 and 5.8±0.7 months. There were 27 (55.1%) functional responders (3 no definable 6-month response; 2 missed assessments and 1 long-term lead displacement). No marker predicted response, however, CTx and LBBB trended most towards predicting functional response.
Conclusion No specific biomarkers reached significance for predicting functional response to CRT. CTx showed a trend towards predicting response and warrants further study.
Trial registration number NCT02541773.
| Item Type: | Journal Article | ||||||
|---|---|---|---|---|---|---|---|
| Subjects: | Q Science > QP Physiology R Medicine > R Medicine (General) R Medicine > RC Internal medicine |
||||||
| Divisions: | Faculty of Medicine > Warwick Medical School | ||||||
| Library of Congress Subject Headings (LCSH): | Heart failure -- Treatment, Cardiac pacing, Extracellular matrix, MicroRNA, Biochemical markers -- Diagnostic use | ||||||
| Journal or Publication Title: | Open Heart | ||||||
| Publisher: | B M J Group | ||||||
| ISSN: | 2053-3624 | ||||||
| Official Date: | 18 October 2018 | ||||||
| Dates: |
|
||||||
| Date of first compliant deposit: | 16 January 2020 | ||||||
| Volume: | 5 | ||||||
| Number: | 2 | ||||||
| Article Number: | e000899 | ||||||
| DOI: | 10.1136/openhrt-2018-000899 | ||||||
| Status: | Peer Reviewed | ||||||
| Publication Status: | Published | ||||||
| Access rights to Published version: | Open Access | ||||||
| RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
